Since the first publication a decade ago describing the use of single-cell RNA sequencing (scRNA-seq) in the context of cancer, over 200 datasets and thousands of scRNA-seq studies have been published in cancer biology. scRNA-seq technologies have been applied across dozens of cancer types and a diverse array of study designs to improve our understanding of tumor biology, the tumor microenvironment, and therapeutic responses, and scRNA-seq is on the verge of being used to improve decision-making in the clinic. Computational methodologies and analytical pipelines are key in facilitating scRNA-seq research. Numerous computational methods utilizing the most advanced tools in data science have been developed to extract meaningful insights. Here, we review the advancements in cancer biology gained by scRNA-seq and discuss the computational challenges of the technology that are specific to cancer research.
CITATION STYLE
Aran, D. (2023, August 10). Single-Cell RNA Sequencing for Studying Human Cancers. Annual Review of Biomedical Data Science. Annual Reviews Inc. https://doi.org/10.1146/annurev-biodatasci-020722-091857
Mendeley helps you to discover research relevant for your work.